Predictive Oncology Inc Cash Flow Conversion Efficiency
Predictive Oncology Inc cash flow conversion efficiency. Based on the latest financial reports, Predictive Oncology Inc (POAI) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.65 Million) by net assets ($-77.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Predictive Oncology Inc (2008–2024)
Cash flow conversion efficiency of Predictive Oncology Inc from 2008 to 2024. This chart illustrates how Predictive Oncology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Predictive Oncology Inc (POAI) share price today for real-time trading data and today's change.
Predictive Oncology Inc Cash Flow Conversion Ratio Explained
Predictive Oncology Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Predictive Oncology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Predictive Oncology Inc ranked by their cash flow conversion efficiency. Also see how much is Predictive Oncology Inc worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SciDev Limited
F:INFA
|
0.025x |
|
Clarkson
LSE:CKN
|
-0.046x |
|
Arco Vara AS
F:AV1
|
-0.098x |
|
Dongkuk Refractories & Steel Co. Ltd
KQ:075970
|
0.000x |
|
Binah Capital Group, Inc. Common Stock
NASDAQ:BCG
|
0.054x |
|
SIMPPLE LTD. Ordinary Shares
NASDAQ:SPPL
|
0.712x |
|
Przedsiebiorstwo Przemyslu Spozywczego PEPEES S.A.
WAR:PPS
|
0.120x |
|
CyberOne Co. Ltd.
KQ:356890
|
-0.015x |
Annual Cash Flow Conversion Efficiency for Predictive Oncology Inc (2008–2024)
The table below shows the annual cash flow conversion efficiency of Predictive Oncology Inc from 2008 to 2024. Review financial agility of Predictive Oncology Inc to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-202.61K | $-11.96 Million | 59.008x | +3800.73% |
| 2023-12-31 | $8.27 Million | $-13.19 Million | -1.595x | -180.55% |
| 2022-12-31 | $21.77 Million | $-12.37 Million | -0.568x | -87.45% |
| 2021-12-31 | $40.27 Million | $-12.21 Million | -0.303x | +93.46% |
| 2020-12-31 | $2.64 Million | $-12.26 Million | -4.638x | -496.57% |
| 2019-12-31 | $11.23 Million | $-8.73 Million | -0.778x | +99.21% |
| 2018-12-31 | $53.47K | $-5.29 Million | -98.890x | -5869.03% |
| 2017-12-31 | $2.69 Million | $-4.46 Million | -1.657x | +65.07% |
| 2016-12-31 | $923.68K | $-4.38 Million | -4.743x | -160.55% |
| 2015-12-31 | $4.11 Million | $-7.49 Million | -1.821x | -397.87% |
| 2014-12-31 | $-5.52 Million | $-3.37 Million | 0.611x | -48.98% |
| 2013-12-31 | $-3.22 Million | $-3.86 Million | 1.198x | +234.13% |
| 2012-12-31 | $-3.30 Million | $-1.18 Million | 0.358x | -45.61% |
| 2011-12-31 | $-2.70 Million | $-1.78 Million | 0.659x | +75.84% |
| 2010-12-31 | $-2.19 Million | $-820.68K | 0.375x | -32.99% |
| 2009-12-31 | $-2.34 Million | $-1.31 Million | 0.559x | -80.78% |
| 2008-12-31 | $-309.44K | $-900.53K | 2.910x | -- |
About Predictive Oncology Inc
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D cult… Read more